-
Non Regulatory December 29, 2020Oasmia Secures Valuable IP Rights in Australia and Brazil
-
Regulatory December 28, 2020Oasmia’s partner Elevar Therapeutics signs licensing agreement with Inceptua Group for the commercialization of Apealea® (paclitaxel micellar) in Europe
-
Regulatory December 9, 2020Interim report1 for the period May 1, 2020 – October 31, 2020
Oasmia Pharmaceutical published its interim report for the second quarter of 2020 on December 9, 2020, at 08.00 am CET.
Oasmia and Elevar sign a global strategic partnership for the commercialization of Apealea®